INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

830 studies · page 17 of 35

2015 / Clinical review

Gastroesophageal reflux in infants and youth can be managed with feeding, diet, and lifestyle adjustments alongside medications when necessary.

Gastroesophageal reflux is a normal physiologic process, whereas GERD causes troublesome symptoms or complications. Diagnoses rely on history and physical examination, with specialized testing reserved for atypical symptoms or suspected complications. In infants, management options include positioning changes while awake, lower-volume feedings, thickening agents like rice cereal, antiregurgitant or hydrolyzed formulas, and maternal elimination of cow's milk and eggs in breastfed infants. For children and adolescents, lifestyle recommendations include sleep position changes, weight loss, and avoiding alcohol, smoking, and late evening meals.

Baird DC, Harker DJ, Karmes AS Am Fam Physician, 2015. PMID 26554410

2014 / Narrative review of patient-targeted dietary recommendations

Patient-targeted dietary recommendations for inflammatory bowel disease focus heavily on food restrictions and are highly conflicting.

This review aimed to identify patient-targeted dietary recommendations for inflammatory bowel disease (IBD) and appraise their nutritional value. The authors reviewed patient-targeted dietary information gathered from structured Internet searches and popular defined diets. They found that these recommendations focus largely on food restrictions and are highly conflicting. The authors note that data showing dietary changes can alter the natural history of IBD are scarce, highlighting the need for high-quality dietary intervention studies.

Hou JK, Lee D, Lewis J Clin Gastroenterol Hepatol, 2014. PMID 24107394

2014 / Narrative review

A review notes limited evidence for pediatric GERD management and cautions against simultaneous overdiagnosis of GERD and cow's milk protein allergy.

Researchers reviewed literature up to May 2013 across multiple databases to assess scientific evidence for pediatric GERD diagnosis and treatment. The review found that simultaneous treatment of GERD and cow's milk protein allergy often leads to unnecessary medication or elimination diets. In addition, abdominal ultrasonography should not be recommended for investigating GER, and there is little evidence supporting acid suppression in the first year of life for nonspecific symptoms.

Ferreira CT, Carvalho Ed, Sdepanian VL, et al. J Pediatr (Rio J), 2014. PMID 24184302

2014 / Narrative review

The intestinal microbiome is a potential therapeutic target in the development and treatment of cardio-metabolic diseases.

Recent studies suggest a potential role for intestinal microbes in the expression of certain human cardio-metabolic diseases. Mechanisms through which gut microbiota and their metabolic products affect systemic homeostasis and cardio-metabolic risks are beginning to be uncovered. Human intervention studies focused on altering microbial composition or pharmacologically manipulating microbiota to influence metabolite production are needed next steps.

Vinjé S, Stroes E, Nieuwdorp M, et al. Eur Heart J, 2014. PMID 24216389

2014 / Narrative review

A review reports that dietary factors, the microbiome, and lifestyle changes modestly influence nonalcoholic fatty liver disease.

This review evaluates recent research on how diet, nutrients, and the microbiome contribute to nonalcoholic fatty liver disease (NAFLD). The authors note that fructose appears to be associated with NAFLD severity, while several studies demonstrate that the Mediterranean diet and 'lifestyle change' are effective in modestly improving NAFLD. A study in children reported simultaneous improvements in cardiovascular disease risk measurements and hepatic steatosis. The review concludes that current data supports limiting sugar in the diet and 'lifestyle change' as a first-line treatment for NAFLD, with modest observed benefits.

Vos MB Curr Opin Lipidol, 2014. PMID 24366230

2014 / Narrative review

Dietary modulation of gut microbiota via whole-plant foods, prebiotics, and probiotics may help manage cardiovascular risk.

This review summarizes evidence connecting gut microbiome activities with cardiovascular disease (CVD) and dietary modulation. Aberrant gut microbiota profiles are linked to obesity, diabetes, and non-alcoholic fatty liver disease, while microbial metabolites from choline, phosphatidylcholine, and l-carnitine directly contribute to CVD pathology. In human studies, selected bile-salt hydrolysing probiotic strains lowered blood cholesterol, and fermentable fibers and plant polyphenols appear to regulate microbial activities. The review concludes that dietary strategies modulating gut microbiota are emerging as efficacious tools for reducing CVD risk, suggesting the way to a healthy heart may be through a healthy gut.

Tuohy KM, Fava F, Viola R Proc Nutr Soc, 2014. PMID 24495527

2014 / Narrative review

A review describes how diet influences the intestinal microbiome structure and metabolome, with potential implications for health and disease.

This review examines the mutual relationship between diet and the intestinal microbiota in mammalian hosts. It highlights that nutrient consumption influences microbial community structure and provides substrates for microbial metabolism, generating small molecules that affect host physiological processes. It notes diet-related microbial differences, such as in breastfed versus formula-fed infants and agrarian plant-based versus meat- and fat-rich Western diets, and discusses implications for conditions like coronary vascular disease and inflammatory bowel disease.

Shows an association, not proof of cause and effect.

Albenberg LG, Wu GD Gastroenterology, 2014. PMID 24503132

2014 / Narrative review

Risk factors for gastroesophageal reflux disease include obesity, poor diet, lack of physical activity, alcohol, tobacco, and respiratory diseases.

This review summarizes the epidemiology, complications, healthcare costs, and risk factors of gastroesophageal reflux disease (GERD). The prevalence of GERD symptoms rose approximately 50% until the mid-1990s before plateauing, alongside shifting trends in complications like esophageal adenocarcinoma and strictures. Reported risk factors for GERD include obesity, poor diet, lack of physical activity, consumption of tobacco and alcohol, and respiratory diseases.

Shows an association, not proof of cause and effect.

Rubenstein JH, Chen JW Gastroenterol Clin North Am, 2014. PMID 24503355

2014 / Narrative review

Intestinal microbiota and fecal transplantation are implicated in regulating human glucose and lipid metabolism in insulin resistance and type 2 diabetes.

This review examines the role of intestinal microbiota and fecal transplantation in insulin resistance and type 2 diabetes mellitus. Alterations in intestinal microbiota composition promote systemic inflammation, which is a hallmark of obesity and subsequent insulin resistance. Fecal transplantation studies indicate that butyrate-producing intestinal bacteria are crucial key players in regulating diverse signaling cascades linked to human glucose and lipid metabolism.

Udayappan SD, Hartstra AV, Dallinga-Thie GM, et al. Clin Exp Immunol, 2014. PMID 24528224

2014 / Narrative review

A macrobiotic Ma-Pi 2 diet and prebiotic-rich diets may help manage type 2 diabetes by modulating gut microbiota.

This review discusses the influence of diet, gut microbiota, and inflammation on type 2 diabetes mellitus (T2DM). High-fat diets can promote dysbiosis and inflammation, whereas prebiotics may reduce inflammation, improve insulin resistance, and regulate appetite hormones. A recent 21-day intervention study in T2DM patients reported that the macrobiotic Ma-Pi 2 diet significantly improved fasting blood glucose, plasma lipid fractions, plasma insulin, and homeostasis. The authors note that these effects must be confirmed in larger randomized controlled trials evaluating indicators of inflammation.

Fallucca F, Porrata C, Fallucca S, et al. Diabetes Metab Res Rev, 2014. PMID 24532292

2014 / Literature review

A review of non-celiac gluten sensitivity notes that diagnosis requires excluding celiac disease and wheat allergy, and patients improve on a gluten-free diet.

This literature review assessed international studies from PubMed and Medline to define current pathogenic, clinical, and diagnostic criteria for non-celiac gluten sensitivity (NCGS). Most NCGS patients report both gastrointestinal and nongastrointestinal symptoms that improve on a gluten-free diet, although they test negative for celiac disease and wheat allergy. NCGS patients represent a heterogeneous group, and diagnosis currently requires excluding celiac disease and wheat allergy. Features such as infant food allergy history, coexistent atopy, positive IgG antigliadin antibodies, basophil activation tests, and intestinal eosinophil counts may help identify these patients.

Mansueto P, Seidita A, D'Alcamo A, et al. J Am Coll Nutr, 2014. PMID 24533607

2014 / Narrative review

Hidradenitis suppurativa is an under-recognised inflammatory skin disease with risk factors that include obesity and smoking.

This review summarizes hidradenitis suppurativa (HS), a chronic, relapsing, inflammatory skin condition typically occurring after puberty with an estimated worldwide prevalence of 1-4%. It is three times more common in women than men and presents as painful inflamed nodules progressing to abscesses and scarring. Recognized risk factors for HS include smoking and obesity, and comorbidities include inflammatory bowel disease and spondyloarthropathies.

Shows an association, not proof of cause and effect.

Dufour DN, Emtestam L, Jemec GB Postgrad Med J, 2014. PMID 24567417

2014 / Narrative review

Complementary and alternative therapies, including herbal options like peppermint oil, show improved treatment outcomes in irritable bowel syndrome.

This review evaluates complementary and alternative medicines (CAM) alongside pharmacological options for irritable bowel syndrome (IBS). Clinical trials over the past decade show that specific herbal therapies (peppermint oil and Iberogast), hypnotherapy, cognitive behavior therapy, acupuncture, and yoga provide improved treatment outcomes. The authors propose an integrative approach combining pharmacotherapy with CAM to optimize patient care and quality of life.

Grundmann O, Yoon SL World J Gastroenterol, 2014. PMID 24574705

2014 / Narrative review

Dietary manipulation of gut microbiota through diet patterns, prebiotics, and probiotics shows potential to prevent metabolic disorders like obesity.

This review discusses the interactions between diet, gut microbiota, and host immune functions in relation to metabolic disorders. The gut microbial composition changes dynamically in response to factors such as host genetics, age, and environment. Dietary regulation affects microbial metabolism and host immunity via mechanisms including nutrient fermentation, intestinal barrier function, gene expression, and immune responses. Modulating gut microbiota through diet patterns, probiotics, prebiotics, and antibiotics shows potential for preventing obesity.

Chen J, He X, Huang J J Food Sci, 2014. PMID 24621052

2014 / Narrative review

Obesity is linked to hepatocellular carcinoma via mechanisms including chronic inflammation, lipotoxicity, altered gut microbiota, and insulin resistance.

This review details how obesity and related metabolic conditions contribute to hepatocarcinogenesis. Obesity-associated hepatocellular carcinoma is attributed to chronic inflammation from adipose remodeling, pro-inflammatory adipokine secretion, ectopic lipid accumulation, altered gut microbiota, disrupted stellate cell senescence, and insulin resistance with elevated insulin and insulin-like growth factors. These pathways synergize with chronic liver disease from other etiologies to accelerate hepatocellular carcinoma development.

Shows an association, not proof of cause and effect.

Karagozian R, Derdák Z, Baffy G Metabolism, 2014. PMID 24629562

2014 / Narrative review

A review evaluates human studies investigating the effects of seaweed and its bioactive components on markers of health and chronic disease.

Seaweeds are rich in unique bioactive compounds such as specific proteins, polyphenols, and polysaccharides with purported antiviral, anticancer, anticoagulant, gut health, obesity, and diabetes benefits. Although most research has been conducted in cell and animal models, evidence exists for the beneficial effects of seaweed and seaweed components on markers of human health and disease status. This review critically evaluates these human studies to highlight gaps in current knowledge and support future research planning.

Brown ES, Allsopp PJ, Magee PJ, et al. Nutr Rev, 2014. PMID 24697280

2014 / Narrative review

A review concludes that calcium supplements provide little fracture prevention benefit while likely increasing risks of adverse events.

This review evaluates the role of calcium supplements in osteoporosis prevention. While calcium acts as a weak antiresorptive and slows postmenopausal bone loss, recent meta-analyses indicate no significant prevention of fractures. Meanwhile, supplement use is likely associated with increased cardiovascular events, kidney stones, gastrointestinal symptoms, and hospital admissions for acute gastrointestinal issues. Consequently, the review suggests obtaining calcium from dietary sources instead, noting that dietary calcium has not been linked to the adverse effects seen with supplements.

Reid IR J Bone Metab, 2014. PMID 24707464

2014 / Narrative review

Dietary factors and gut microbiota dysbiosis appear to influence type 1 diabetes development, though evidence remains inconclusive.

This review examines the influence of dietary and environmental factors, alongside gut microbiota, on type 1 diabetes (T1D) etiology in humans and animal models. Even in mono-zygotic twins, the concordance rate is only around 50%, highlighting the role of non-genetic factors. Although data remain inconclusive, there are strong indications that gut microbiota dysbiosis plays an important role, and animal models suggest manipulating the gut microbiota may be valuable for future prevention in genetically susceptible individuals.

Nielsen DS, Krych Ł, Buschard K, et al. FEBS Lett, 2014. PMID 24746688

2014 / Narrative review

Gut microbiota dysbiosis, including reduced levels of butyrate-producing bacteria, is linked to type 2 diabetes and metabolic alterations.

This review discusses the relationship between gut microbiota, obesity, and type 2 diabetes (T2D). Human metagenome-wide association studies show significant correlations between specific intestinal bacteria, bacterial genes, and metabolic pathways with T2D. Notably, concentrations of butyrate-producing bacteria such as Roseburia intestinalis and Faecalibacterium prausnitzii were lower in T2D subjects. Additionally, gut-derived endotoxaemia is observed in metabolic syndrome and T2D, and specific bacteria like Akkermansia muciniphila may be decreased in diabetes and exert antidiabetic effects in murine models.

Shows an association, not proof of cause and effect.

Tilg H, Moschen AR Gut, 2014. PMID 24833634

2014 / Narrative review

A review notes that a low-FODMAP diet, antispasmodics, and specific pharmacological agents can help manage abdominal pain in irritable bowel syndrome.

This review evaluates pharmacological and non-pharmacological treatment options targeting the central nervous system and gastrointestinal tract for irritable bowel syndrome (IBS) abdominal pain. A diet low in fermentable carbohydrates and polyols (FODMAP) seems effective in subgroups of patients to reduce abdominal pain and bloating and improve stool pattern, while fiber evidence is limited with only ispaghula showing some benefit. Antispasmodics, including peppermint oil, remain first-line treatments for abdominal pain, alongside various second-line therapies tailored to IBS subtypes.

Vanuytsel T, Tack JF, Boeckxstaens GE J Gastroenterol, 2014. PMID 24845149

2014 / Narrative review

Plant-based dietary patterns and components like fiber may alter the gut microbiota to influence cardiometabolic risk.

This review examines the influence of dietary patterns and their components on the gut microbiota and cardiometabolic outcomes. Dietary patterns emphasizing plant-based foods, such as vegetarian and vegan diets, have been linked to a reduced risk of cardiovascular events and diabetes incidence. These diets provide high levels of dietary fiber and fermentable substrates that gut microbes ferment into short-chain fatty acids, which may modulate host health. Prebiotics and resistant starches are noted as dietary components that alter gut microbial composition.

Wong JM Am J Clin Nutr, 2014. PMID 24898225

2014 / Narrative review

Review proposes dietary factors like animal fat, high sugar, and emulsifiers may impair bacterial clearance and trigger gut inflammation in Crohn's disease.

This review discusses dietary clues in the pathogenesis of Crohn's disease, highlighting the effectiveness of exclusive enteral nutrition (EEN) in children and the requirement of complete exclusion of normal diet. The authors propose the 'bacterial penetration cycle' model, wherein dietary components such as animal fat, high sugar intake, gliadin, emulsifiers, maltodextrin, and low-fiber diets may induce a localized bacterial clearance defect. This defect potentially leads to bacterial adhesion, penetration, and gut inflammation.

Pfeffer-Gik T, Levine A Dig Dis, 2014. PMID 24969285

2014 / Review

Fiber supplementation and peppermint oil are among the therapies with the most reliable evidence supporting their use for irritable bowel syndrome symptoms.

This review evaluates the evidence supporting medication and management options for specific irritable bowel syndrome (IBS) symptoms. Several agents show evidence of symptom improvement, with rifaximin, lubiprostone, linaclotide, fiber supplementation (including psyllium and bran), and peppermint oil possessing the most reliable evidence supporting their use. Onset of efficacy occurred as early as 6 days after initiation, though efficacy for most medications was not assessed prospectively at predefined periods. Additional studies are noted to be needed to better define their place in therapy.

Trinkley KE, Nahata MC Digestion, 2014. PMID 24992947

2014 / Conference proceedings

A summit identified the need to clarify fiber sources and promote diverse foods to help Americans meet daily fiber recommendations.

The Food & Fiber Summit convened nutrition researchers, educators, and communicators to address persistently low fiber intake in America, which remains at approximately half of recommended amounts. Adequate fiber intake is associated with reduced risk for cardiovascular disease, cancer, diabetes, certain gastrointestinal disorders, and obesity. Summit outcomes emphasized addressing consumer confusion regarding fiber sources, recognizing benefits of various fiber types, and identifying practical opportunities across meal occasions and food categories to increase intake.

Shows an association, not proof of cause and effect.

Mobley AR, Jones JM, Rodriguez J, et al. Nutrients, 2014. PMID 25006857